Lee M Kaplan Selected Research

Lee M Kaplan Research Topics

Disease

26	Obesity 05/2022 - 03/2005
26	Weight Loss (Weight Reduction) 05/2022 - 03/2005
9	Morbid Obesity 05/2022 - 10/2009
8	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2010
7	Insulin Resistance 01/2018 - 12/2008
6	Body Weight (Weight, Body) 01/2016 - 12/2008
4	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2017
4	Overweight 01/2019 - 01/2012
3	Hyperglycemia 01/2017 - 06/2016
2	Fibrosis (Cirrhosis) 01/2019 - 01/2017
2	Diabetes Mellitus 02/2016 - 11/2010
2	Hypertension (High Blood Pressure) 02/2016 - 01/2015
2	Inflammation (Inflammations) 03/2013 - 12/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 12/2009
2	Starvation 03/2010 - 03/2005
1	Frailty 01/2021
1	Prediabetic State (Prediabetes) 01/2019
1	Fatty Liver 07/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2015
1	Clostridium Infections 02/2014
1	Malnutrition (Nutritional Deficiencies) 11/2010
1	Metabolic Diseases (Metabolic Disease) 10/2009

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 12/2008
4	salicylhydroxamic acid (SHAM)IBA 07/2013 - 12/2008
3	Insulin (Novolin)FDA Link 02/2016 - 12/2008
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 05/2022 - 06/2012
2	HydrogelsIBA 07/2019 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2016 - 02/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 11/2012
2	Natriuretic PeptidesIBA 01/2015 - 11/2010
2	Biological ProductsIBA 05/2013 - 10/2011
2	Hormones (Hormone)IBA 01/2012 - 01/2010
1	anandamide (arachidonylethanolamide)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	ConnexinsIBA 07/2018
1	Gap Junction beta-1 ProteinIBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 07/2018
1	IncretinsIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2017
1	Antihypertensive Agents (Antihypertensives)IBA 02/2016
1	DiureticsIBA 02/2016
1	MicroRNAs (MicroRNA)IBA 11/2015
1	5-HT2C Serotonin ReceptorIBA 09/2015
1	Complement System Proteins (Complement)IBA 09/2015
1	SaltsIBA 01/2015
1	Investigational DrugsIBA 02/2014
1	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 05/2013
1	Volatile Fatty AcidsIBA 03/2013
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2013
1	MelanocortinsIBA 06/2012
1	CalciumIBA 01/2012
1	AdiponectinIBA 01/2012
1	Vitamin D FDA LinkGeneric 01/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2010
1	pro-brain natriuretic peptide (1-76)IBA 11/2010
1	CholesterolIBA 08/2010
1	HDL CholesterolIBA 08/2010
1	Triglycerides (Triacylglycerol)IBA 08/2010
1	LDL CholesterolIBA 08/2010
1	LipidsIBA 12/2009
1	A 17 (A-17)IBA 10/2009
1	Topiramate (Topamax)FDA LinkGeneric 03/2005
1	Orlistat (Xenical)FDA Link 03/2005
1	sibutramine (Meridia)FDA Link 03/2005
1	Zonisamide (Zonegran)FDA LinkGeneric 03/2005
1	Bupropion (Wellbutrin)FDA LinkGeneric 03/2005
1	Metformin (Glucophage)FDA LinkGeneric 03/2005
1	Phentermine (Adipex-P)FDA LinkGeneric 03/2005

Therapy/Procedure

17	Bariatric Surgery 05/2022 - 09/2008
16	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2019 - 12/2008
14	Therapeutics 01/2019 - 03/2005
3	Injections 01/2017 - 06/2016
2	Obesity Management 01/2021 - 01/2018
2	Gastrectomy 01/2019 - 04/2017
1	Operative Surgical Procedures 01/2018
1	Biliopancreatic Diversion 04/2017
1	Liver Transplantation 01/2017
1	Fecal Microbiota Transplantation 02/2014
1	Glycemic Control 11/2012
1	Perioperative Period 03/2005